首页> 外国专利> METHOD FOR CURING THE CASES OF BRONCHIAL ASTHMA IN CHILDREN IN PAROXYSMAL PERIOD

METHOD FOR CURING THE CASES OF BRONCHIAL ASTHMA IN CHILDREN IN PAROXYSMAL PERIOD

机译:阵发性儿童支气管哮喘病例的治疗方法

摘要

the invention u043eu0442u043du043eu0441u0438u0442u0441u00a0 to medicine, in particular to the pulmonology and paediatrics. the purpose of the timing u043au0443u043fu0438u0440u043eu0432u0430u043du0438u00a0 attack and complications of therapy. u0434u043bu00a0 this during the first 3 h u043fu0440u0438u0441u0442u0443u043fu043du043eu0433u043e period u043du0430u0440u00a0u0434u0443 with intravenous introduction of u044du0443u0444u0438u043bu043bu0438u043du0430 against symptomatic therapy in addition to u0432u0432u043eu0434u00a0u0442 iv u0430u043fu0435u043bu044cu043du043e u0442u0440u0435u043du0442u0430u043b in a dose of 2 mg / kg body weight and oral u043du043eu043du0430u0445u043bu0430u0437u0438u043d 15 mg.introduction drugs continue to be in the next 5 to 7 days. u0442u0440u0435u043du0442u0430u043b u0432u0432u043eu0434u00a0u0442 in the same mode, u043du043eu043du0430u0445u043bu0430u0437u0438u043d to 30 mg once a day. this helps to reduce the time for u043au0443u043fu0438u0440u043eu0432u0430u043du0438u00a0 attack up to 3 to 5 hours, the prevention of the side effects of large doses of u044du0443u0444u0438u043bu043bu0438u043du0430 and reduce the complications of therapy by u0438u0441u043au043bu044eu0447u0435u043du0438u00a0 u0441u0438u043cu043fu0430u0442u043eu043cu0438u043cu0435u0442u0438u043au043eu0432 of immediate therapy.
机译:本发明涉及医学,特别是涉及肺科和儿科。定时发作的目的和治疗的并发症。 u0434 u043b u00a0在开始的3小时内 u043f u0440 u0438 u0441 u0442 u0443 u043f u043d u043e u043e u0433 u043e期间 u043d u0430 u0440 u0440 u00a0 u0434 u0443 u044d u0443 u0444 u0438 u043b u043b u0438 u043d u0430除针对 u0432 u0432 u043e u0434 u00a0 u0442 iv u0430 u043f u0435 u043b u043c u043e u0442 u0440 u0435 u043d u0442 u0430 u043b的剂量为2 mg / kg体重,并且口服 u043d u043e u043d u043d u0430 u0445 u043b u0430 u0430 u0437 u0438 u043d 15在接下来的5到7天内继续使用mg.introduction药物。 u0442 u0440 u0435 u043d u0442 u0430 u043b u0432 u0432 u043e u0434 u00a0 u0442在相同模式下, u043d u043e u043d u0430 u0445 u043b u0430 u0437 u0438 u043d每天一次30毫克。这有助于将 u043a u0443 u043f u0438 u0440 u043e u0432 u0430 u043d u0438 u00a0攻击的时间缩短3至5小时,从而避免了大剂量 u044d 的副作用u0443 u0444 u0438 u043b u043b u0438 u043d u0430并通过 u0438 u0441 u043a u043b u043e u0447 u0435 u043d u0438 u00a0 u0441 u0438 u043c u043f来减少治疗并发症 u0430 u0442 u043e u043c u0438 u043c u0435 u0442 u0438 u043a u043e u0432立即治疗。

著录项

  • 公开/公告号SU1673120A1

    专利类型

  • 公开/公告日1991-08-30

    原文格式PDF

  • 申请/专利权人 DN MED INSTITUT;

    申请/专利号SU19874182665

  • 发明设计人 DUKA EKATERINA DSU;BOGOMAZ TAMARA ASU;

    申请日1987-01-14

  • 分类号A61K31/522;A61K31/5415;A61P11/06;

  • 国家 SU

  • 入库时间 2022-08-22 05:50:37

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号